A newer conversion equation for the correlation between HbA1c and glycated albumin

Endocrine Journal

Volumn 61, Issue 6, 2014, Pages 553-560

  Inoue, Kaori ^a,b   Tsujimoto, Tetsuro ^a   Yamamoto Honda, Ritsuko ^a   Goto, Atsushi ^a,b   Kishimoto, Miyako ^a   Noto, Hiroshi ^a   Kajio, Hiroshi ^a   Doi, Seiichi ^a   Miyazaki, Sumio ^a   Terauchi, Yasuo ^b   Noda, Mitsuhiko ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Glycated albumin; Glycated hemoglobin

Indexed keywords

GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED SERUM ALBUMIN; HEMOGLOBIN A1C PROTEIN, HUMAN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLYCEMIC CONTROL; HEMATOLOGIC MALIGNANCY; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; STEROID THERAPY; STRUCTURAL EQUATION MODELING; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; THEORETICAL MODEL;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PREGNANCY; SERUM ALBUMIN;

EID: 84903599634     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0450     Document Type: Article

References (26)

1. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
2. Tahara Y, Shima S (1995) Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447.
3. Matsumoto H, Murase-Mishiba Y, Yamamoto N, Sugitatsu-Nakatsukasa S, Shibasaki S, et al. (2012) Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Intern Med 51: 1315-1321.
4. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, et al. (2008) Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J 55: 503-507.
5. Sakuma N, Omura M, Oda E, Saito T (2011) Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin. Diabetol Int 2: 162-171.
6. Panzer S, Kronik G, Lechner K, Bettelheim P, Neumann E, et al. (1982) Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 59: 1348-1350.
7. Kim C, Bullard KM, Herman WH, Beckles GL (2010) Association between iron defciency and A1c levels among adults without diabetes in the national health and nutrition examination survey, 1999-2006. Diabetes Care 33: 780-785.
8. Hashimoto K, Noguchi S, Morimoto Y, Hamada S, Wasada K, et al. (2008) A1C but not serum glycated albumin is elevated in late pregnancy owing to iron def-ciency. Diabetes Care 31: 1945-1948.
9. Hashimoto K, Osugi T, Noguchi S, Morimoto Y, Wasada K, et al. (2010) A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care 33: 509-511.
10. Koga M, Kasayama S, Kanehara H, Bando Y (2008) CLD (chronic liver diseases)-HbA1c as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver disease. Diabetes Res Clin Pract 81: 258-262.
11. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, et al. (2008) Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodi-alysis. Kidney Int 73: 1062-1068.
12. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, et al. (2011) Infuence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med 50: 23-29.
13. Koga M, Murai J, Saito H, Matsumoto S, Kasayama S (2009) Effects of thyroid hormone on serum gly-cated albumin levels: Study on non-diabetic subjects. Diabetes Res Clin Pract 84: 163-167.
14. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, et al. (2012) International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 3: 8-10.
15. Efron B (1982) The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia: Society for Industrial and Applied Mathematics
16. The Diabetes Control and Complications Trial research group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
17. UK Prospective Diabetes Study (UKPDS) group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 352: 837-853.
18. Okubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
19. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, et al. (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924.
20. The DECODE study group on behalf of the European Diabetes Epidemiology group (2004) Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE study. Diabetologia 47: 2118-2128.
21. Nathan DM, McGee P, Steffes MW, Lachin JM and the DCCT/EDIC research group (2014) Relationship of glycated albumin to blood glucose and glycated hemo-globin (HbA1c) values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT/EDIC study. Diabetes 63: 282-290.
22. Li JP, Lin L, Wei FS, Qi Z, Rui YZ, et al. (2007) Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J 71: 1067-1073.
23. Nathan DM, Steffes MW, Sun W, Rynders GP, Lachin JM (2011) Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem 57: 286-290.
24. Tahara Y (2009) Analysis of the method for conversion between levels of HbA1c and glycated albumin by liner regression analysis using a measurement error model. Diabetes Res Clin Pract 84: 224-229.
25. Nishimura R, Kanda A, Sano H, Matsudaira T, Miyashita Y, et al. (2006) Glycated albumin is low in obese, non-diabetic children. Diabetes Res Clin Pract 71: 334-338.
26. Koga M, Matsumoto S, Saito H, Kasayama S (2006) Body mass index negatively infuences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J 53: 387-391.